Study identifier:NIS-CFR-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Evaluation of target organs impairment on patients suffering from high blood pressure without known cardio vascular or renal disease, stratified on blood pressure control.
blood pressure
-
No
-
All
1200
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
Evaluation of target organs impairment on patients suffering from high blood pressure without known cardio vascular or renal disease, stratified on blood pressure control.
Location
Location
ABBEVILLE, France
Location
AIRE SUR L ADOUR CEDEX, France
Location
AIX EN PROVENCE, France
Location
AJACCIO, France
Location
ALBI, France
Location
ALENCON, France
Location
ALES, France
Location
AMBERIEU EN BUGEY, France
Arms | Assigned Interventions |
---|---|
1 | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.